The Community Guide

- gsearch

Search Results

Narrow Results:

2021 7
2016 1
2013 1

U.S. 1
United States 1

Conference Publications 5
Tables 1

1 - 9 of 9 Results

Refine Results

Refine Results:

Cough and Cold Medication Adverse Events After Market Withdrawal and Labeling Revision

CITE Title : Cough and Cold Medication Adverse Events After Market Withdrawal and Labeling Revision Personal Author(s) : Hampton, Lee M.;Nguyen, Duc B.;Edwards, Jonathan R.;Budnitz, Daniel S.; Published Date : Nov 11 2013 Source : Pediatrics. 132(6):1047-1054. URL : https://stacks.cdc.gov/view/cdc/37138 Hampton, Lee M. et al. (2013). Cough and Cold Medication Adverse Events After Market Withdrawal and Labeling Revision. 132(6). Hampton, Lee M. et al. "Cough and Cold Medication Adverse Events After Market Withdrawal and Labeling Revision" 132, no. 6 (2013) Hampton, Lee M. et al. "Cough and Cold Medication Adverse Events After Market Withdrawal and Labeling Revision" vol. 132, no. 6, 2013 Export RIS Citation Information.

:

Hampton, Lee M. ;

Nguyen, Duc B.

Nov 11 2013 | Pediatrics. 132(6):1047-1054.

:

BACKGROUNDIn October 2007, manufacturers voluntarily withdrew over-the-counter (OTC) infant cough and cold medications (CCMs) from the US market. A ye...
Reports of cerebral venous sinus thrombosis with thrombocytopenia after Janssen COVID-19 vaccine

CITE Title : Reports of cerebral venous sinus thrombosis with thrombocytopenia after Janssen COVID-19 vaccine Personal Author(s) : Shimabukuro, Tom T. Corporate Authors(s) : CDC COVID-19 Vaccine Task Force. Vaccine Safety Team. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2021 Feb. April 14: Atlanta, GA) Published Date : April 14, 2021 Series : ACIP meeting COVID-19 Vaccines URL : https://stacks.cdc.gov/view/cdc/105791 Shimabukuro, Tom T. (2021). Reports of cerebral venous sinus thrombosis with thrombocytopenia after Janssen COVID-19 vaccine. 202104(0100103). Shimabukuro, Tom T. "Reports of cerebral venous sinus thrombosis with thrombocytopenia after Janssen COVID-19 vaccine" 202104, no. 0100103 (2021) Shimabukuro, Tom T. "Reports of cerebral venous sinus thrombosis with thrombocytopenia after Janssen COVID-19 vaccine" vol. 202104, no. 0100103, 2021 Export RIS Citation Information.

:

Shimabukuro, Tom T.

April 14, 2021 | ACIP meeting COVID-19 Vaccines

:

03-COVID-Shimabukuro-508.pdf
Thrombocytopenic thrombosis after Janssen vaccine : Work Group interpretation

CITE Title : Thrombocytopenic thrombosis after Janssen vaccine : Work Group interpretation Personal Author(s) : Oliver, Sara E. Corporate Authors(s) : United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2021 Feb. April 14: Atlanta, GA) Published Date : April 14, 2021 Series : ACIP meeting COVID-19 Vaccines URL : https://stacks.cdc.gov/view/cdc/105793 Oliver, Sara E. (2021). Thrombocytopenic thrombosis after Janssen vaccine : Work Group interpretation. 202104(0100105). Oliver, Sara E. "Thrombocytopenic thrombosis after Janssen vaccine : Work Group interpretation" 202104, no. 0100105 (2021) Oliver, Sara E. "Thrombocytopenic thrombosis after Janssen vaccine : Work Group interpretation" vol. 202104, no. 0100105, 2021 Export RIS Citation Information.

:

Oliver, Sara E.

April 14, 2021 | ACIP meeting COVID-19 Vaccines

:

05-COVID-Oliver-508.pdf
Update: Thrombosis with thrombocytopenia syndrome (TTS) following COVID-19 vaccination

CITE Title : Update: Thrombosis with thrombocytopenia syndrome (TTS) following COVID-19 vaccination Personal Author(s) : Shimabukuro, Tom T. Corporate Authors(s) : CDC COVID-19 Vaccine Task Force. Vaccine Safety Team. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2021 May 12: Atlanta, GA) Published Date : 05/12/2021 Series : ACIP meeting COVID-19 Vaccines URL : https://stacks.cdc.gov/view/cdc/107715 Shimabukuro, Tom T. (2021). Update: Thrombosis with thrombocytopenia syndrome (TTS) following COVID-19 vaccination. 202107(0100107). Shimabukuro, Tom T. "Update: Thrombosis with thrombocytopenia syndrome (TTS) following COVID-19 vaccination" 202107, no. 0100107 (2021) Shimabukuro, Tom T. "Update: Thrombosis with thrombocytopenia syndrome (TTS) following COVID-19 vaccination" vol. 202107, no. 0100107, 2021 Export RIS Citation Information.

:

Shimabukuro, Tom T.

05/12/2021 | ACIP meeting COVID-19 Vaccines

:

07-COVID-Shimabukuro-508.pdf
Risk/Benefit assessment of thrombotic thrombocytopenic events after Janssen COVID-19 vaccines : Applying evidence to recommendation framework

CITE Title : Risk/Benefit assessment of thrombotic thrombocytopenic events after Janssen COVID-19 vaccines : Applying evidence to recommendation framework Personal Author(s) : Oliver, Sara E. Corporate Authors(s) : United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2021 Feb. April 14: Atlanta, GA) Published Date : April 23, 2021 Series : ACIP meeting COVID-19 Vaccines URL : https://stacks.cdc.gov/view/cdc/107511 Oliver, Sara E. (2021). Risk/Benefit assessment of thrombotic thrombocytopenic events after Janssen COVID-19 vaccines : Applying evidence to recommendation framework. 202105(0100106). Oliver, Sara E. "Risk/Benefit assessment of thrombotic thrombocytopenic events after Janssen COVID-19 vaccines : Applying evidence to recommendation framework" 202105, no. 0100106 (2021) Oliver, Sara E. "Risk/Benefit assessment of thrombotic thrombocytopenic events after Janssen COVID-19 vaccines : Applying evidence to recommendation framework" vol. 202105, no. 0100106, 2021 Export RIS Citation Information.

:

Oliver, Sara E.

April 23, 2021 | ACIP meeting COVID-19 Vaccines

:

During the ACIP meeting, the numbers presented were risks and benefits per two million vaccine doses; numbers have been updated here to reflect risks ...
Thrombosis with thrombocytopenia syndrome (TTS) following Janssen COVID-19 vaccine

CITE Title : Thrombosis with thrombocytopenia syndrome (TTS) following Janssen COVID-19 vaccine Personal Author(s) : Shimabukuro, Tom T. Corporate Authors(s) : CDC COVID-19 Vaccine Task Force. Vaccine Safety Team. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2021 Feb. April 14: Atlanta, GA) Published Date : April 23, 2021 Series : ACIP meeting COVID-19 Vaccines URL : https://stacks.cdc.gov/view/cdc/107508 Shimabukuro, Tom T. (2021). Thrombosis with thrombocytopenia syndrome (TTS) following Janssen COVID-19 vaccine. 202105(0100103). Shimabukuro, Tom T. "Thrombosis with thrombocytopenia syndrome (TTS) following Janssen COVID-19 vaccine" 202105, no. 0100103 (2021) Shimabukuro, Tom T. "Thrombosis with thrombocytopenia syndrome (TTS) following Janssen COVID-19 vaccine" vol. 202105, no. 0100103, 2021 Export RIS Citation Information.

:

Shimabukuro, Tom T.

April 23, 2021 | ACIP meeting COVID-19 Vaccines

:

03-COVID-Shimabukuro-508.pdf
The Globally Synchronized Switch—Another Milestone Toward Achieving Polio Eradication

CITE Title : The Globally Synchronized Switch—Another Milestone Toward Achieving Polio Eradication Personal Author(s) : Wassilak, Steven G. F.;Vertefeuille, John F.;Martin, Rebecca M.; Published Date : 10 01 2016;10-01-; Source : JAMA Pediatr. 170(10):927-928 URL : https://stacks.cdc.gov/view/cdc/129440 Wassilak, Steven G. F. et al. (2016). The Globally Synchronized Switch—Another Milestone Toward Achieving Polio Eradication. 170(10). Wassilak, Steven G. F. and Vertefeuille, John F. and Martin, Rebecca M. "The Globally Synchronized Switch—Another Milestone Toward Achieving Polio Eradication" 170, no. 10 (2016) Wassilak, Steven G. F. et al. "The Globally Synchronized Switch—Another Milestone Toward Achieving Polio Eradication" vol. 170, no. 10, 2016 Export RIS Citation Information.

:

Wassilak, Steven G. F. ;

Vertefeuille, John F.

10 01 2016 | JAMA Pediatr. 170(10):927-928

No Description
Supplementary Table. Demographic Characteristics of V-safe Respondents Who Received Janssen COVID-19 Vaccine and Completed at Least One Health Survey During the 7 Days After Vaccination, March 2–April 12, 2021

CITE Title : Supplementary Table. Demographic Characteristics of V-safe Respondents Who Received Janssen COVID-19 Vaccine and Completed at Least One Health Survey During the 7 Days After Vaccination, March 2–April 12, 2021 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : 04/30/2021 Pages in Document : 1 pdf page Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2021; v. 70 Early Release URL : https://stacks.cdc.gov/view/cdc/105473 Centers for Disease Control and Prevention (U.S.) (2021). Supplementary Table. Demographic Characteristics of V-safe Respondents Who Received Janssen COVID-19 Vaccine and Completed at Least One Health Survey During the 7 Days After Vaccination, March 2–April 12, 2021. 70 Centers for Disease Control and Prevention (U.S.) "Supplementary Table. Demographic Characteristics of V-safe Respondents Who Received Janssen COVID-19 Vaccine and Completed at Least One Health Survey During the 7 Days After Vaccination, March 2–April 12, 2021" 70 (2021) Centers for Disease Control and Prevention (U.S.) "Supplementary Table. Demographic Characteristics of V-safe Respondents Who Received Janssen COVID-19 Vaccine and Completed at Least One Health Survey During the 7 Days After Vaccination, March 2–April 12, 2021" vol. 70, 2021 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.)

04/30/2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

No Description
Vaccine — United States, March–April 2021

CITE Title : Vaccine — United States, March–April 2021 Personal Author(s) : Shay, David K.;Gee, Julianne;Su, John R.;Myers, Tanya R.;Marquez, Paige;Liu, Ruiling;Zhang, Bicheng;Licata, Charles;Clark, Thomas A.;Shimabukuro, Tom T.; Published Date : 5 07 2021 Pages in Document : 5 pdf pages Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR Morbidity Mortal Weekly Rep. 70(18):680-684 DOI : http://dx.doi.org/10.15585/mmwr.mm7018e2 Journal Title : Morbidity and Mortality Weekly Report (MMWR) Shay, David K. et al. (2021). Vaccine — United States, March–April 2021. 70(18). http://dx.doi.org/10.15585/mmwr.mm7018e2 Shay, David K. et al. "Vaccine — United States, March–April 2021" 70, no. 18 (2021), http://dx.doi.org/10.15585/mmwr.mm7018e2 Shay, David K. et al. "Vaccine — United States, March–April 2021" vol. 70, no. 18, 2021, http://dx.doi.org/10.15585/mmwr.mm7018e2 Export RIS Citation Information.

:

Shay, David K. ;

Gee, Julianne

5 07 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

On February 27, 2021, the Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for Janssen (Ad.26.COV2.S) COVID-19 vaccine (...